Health-care shares were lower along with the broader stock
market in pre-market trade Thursday.
In health-care stocks news, Novartis AG (
) American depositary shares slipped in Thursday's pre-market
session, after the Swiss maker of health-care products reported Q2
adjusted earnings and revenue below Street expectations.
NVS was down 1.3% at $88.86 in recent
, in a 52-week range of $70.95 to $91.66.
And, NeoGenomics (
), a provider of cancer-focused genetic-testing services, reported
Q2 earnings in line with analysts' consensus on revenue that
slightly topped the Street view.
Net income was $274,000, or $0.01 per share, compared with $273
million, or $0.01 per share, a year earlier. The per-share result
matched analysts' consensus estimate, according to Capital IQ.
Finally, Baxter International (
) shares were slightly higher in recent pre-market trade after
reporting Q2 earnings and revenues that exceeded analysts'
BAX is trading near the top end of the 52-week range between
$62.80 and $77.14.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.